Skip to main content
Supplement Research and Comparison WebsiteBest Price GuaranteeAbout Us
Supplement Research and Comparison Website

Antimicrobial activity of Lactobacillus salivarius and Lactobacillus fermentum against Staphylococcus aureus

  • 2017-02-02
  • Pathogens and Disease 75(2)
    • Mi-Sun Kang
    • Hae-Soon Lim
    • Jong-Suk Oh
    • Y. Lim
    • K. Wuertz-Kozak
    • Janette M. Harro
    • M. Shirtliff
    • Y. Achermann

Abstract

The increasing prevalence of methicillin-resistant Staphylococcus aureus has become a major public health threat. While lactobacilli were recently found useful in combating various pathogens, limited data exist on their therapeutic potential for S. aureus infections. The aim of this study was to determine whether Lactobacillus salivarius was able to produce bactericidal activities against S. aureus and to determine whether the inhibition was due to a generalized reduction in pH or due to secreted Lactobacillus product(s). We found an 8.6-log10 reduction of planktonic and a 6.3-log10 reduction of biofilm S. aureus. In contrast, the previously described anti-staphylococcal effects of L. fermentum only caused a 4.0-log10 reduction in planktonic S. aureus cells, with no effect on biofilm S. aureus cells. Killing of S. aureus was partially pH dependent, but independent of nutrient depletion. Cell-free supernatant that was pH neutralized and heat inactivated or proteinase K treated had significantly reduced killing of L. salivarius than with pH-neutralized supernatant alone. Proteomic analysis of the L. salivarius secretome identified a total of five secreted proteins including a LysM-containing peptidoglycan binding protein and a protein peptidase M23B. These proteins may represent potential novel anti-staphylococcal agents that could be effective against S. aureus biofilms.

Keywords: Lactobacillus fermentum; Lactobacillus salivarius; LysM; Staphylococcus aureus; antibacterial activity; biofilm.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Lactobacillus SalivariusReduced Staphylococcal InfectionsBeneficial
Moderate
Lactobacillus SalivariusReduced Staphylococcus Aureus InfectionBeneficial
Large
Lactobacillus salivarius HA-118Increased Antipathogen Activity Against Staphylococcus AureusBeneficial
Large
Lactobacillus salivarius UALb-07Reduced Staphylococcus aureus ViabilityBeneficial
Large
Lactobacillus salivarius UALs07Potentially Effective Antibacterial ProteinsBeneficial
Moderate
Lactobacillus salivarius UALs07Reduced Staphylococcal InfectionsBeneficial
Moderate
⬆ Back to top
Unsubscribe anytime. See our Privacy Policy.
Pillser
Supplement Research and Comparison Website: evidence-based information about supplements, their benefits, potential risks, and their efficacy.
Join Our Community
Statements on this website have not been reviewed by the U.S. Food and Drug Administration. These products are not meant to diagnose, treat, cure, or prevent any disease. The information here is not a replacement for personal medical advice.